Table 4.

Group 3: Presence of SARS-CoV-2 antibodies in COVID-19-infected and vaccinated individuals. 3a, COVID-19-infected and vaccinated with vaccine-A; 3b, COVID-19-infected and vaccinated with vaccine-B

a
Group-3a		N size	Abs present	Abs absent	%
	Female	37	36	1	97
	Male	67	65	2	97
	Total	104	101	3	97
b
Group-3b		N size	Abs present	Abs absent	%
	Female	24	23	1	96
	Male	109	107	2	98
	Total	133	130	3	98